C. Hermans

发表

Epidemiology of inhibitor formation with recombinant factor VIII replacement therapy

K. Peerlinck, C. Hermans, 2006, Haemophilia : the official journal of the World Federation of Hemophilia.

ReFacto® 1 and Advate® 2 : a single‐dose, randomized, two‐period crossover pharmacokinetics study in subjects with haemophilia A

P. Mannucci, M. Morfini, C. Kessler, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Modelling of blood pressure and total cardiovascular risk outcomes after second-line valsartan therapy: the BSCORE study.

Yu-ming Shen, R. Lins, I. Abraham, 2011, Archives of cardiovascular diseases.

Predicting blood pressure outcomes using single-item physician-administered measures: a retrospective pooled analysis of observational studies in Belgium.

K. Denhaerynck, I. Abraham, C. Hermans, 2015, The British journal of general practice : the journal of the Royal College of General Practitioners.

Single‐dose pharmacokinetics of porcine factor VIII (Hyate C)

C. Hermans, P. Lilley, G. Longo, 2002, Thrombosis and haemostasis.

Single-dose Pharmacokinetics of Porcine Factor VIII (Hyate C)

C. Hermans, M. Morfini, C. Lee, 2002, Thrombosis and Haemostasis.

Remission Over 3 Years in Patients with Paget Disease of Bone Treated with a Single Intravenous Infusion of 5 mg Zoledronic Acid

P. Geusens, S. Boonen, J. Devogelaer, 2013, Calcified Tissue International.

Hierarchical Modeling of Patient and Physician Determinants of Blood Pressure Outcomes in Adherent vs Nonadherent Hypertensive Patients: Pooled Analysis of 6 Studies With 14,646 Evaluable Patients

K. Denhaerynck, I. Abraham, C. Hermans, 2013, Journal of clinical hypertension.

Effectiveness of Amlodipine-Valsartan Single-Pill Combinations: Hierarchical Modeling of Blood Pressure and Total Cardiovascular Disease Risk Outcomes (the EXCELLENT Study)

Yu-ming Shen, R. Lins, I. Abraham, 2011, The Annals of pharmacotherapy.

Effectiveness of Valsartan for Treatment of Hypertension: Patient Profiling and Hierarchical Modeling of Determinants and Outcomes (the Preview Study)

K. Denhaerynck, I. Abraham, C. Hermans, 2009, The Annals of pharmacotherapy.

Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program

I. Abraham, C. Hermans, K. MacDonald, 2011, Vascular health and risk management.

Hierarchical linear and logistic modeling of outcomes of antihypertensive treatment in elderly patients: findings from the PREVIEW study.

I. Abraham, C. Hermans, P. Van der Niepen, 2010, Archives of gerontology and geriatrics.

Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study

J. Rakic, K. Denhaerynck, I. Abraham, 2013, Clinical ophthalmology.

“Later, lazier, and unluckier”: a heuristic profile of high vulnerability is an independent predictor of uncontrolled blood pressure (the PREVIEW study)

I. Abraham, C. Hermans, P. Van der Niepen, 2010, International journal of general medicine.

Remission Over 3 Years in Patients with Paget Disease of Bone Treated with a Single Intravenous Infusion of 5 mg Zoledronic Acid

P. Geusens, S. Boonen, J. Devogelaer, 2013, Calcified Tissue International.

Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study)

K. Denhaerynck, I. Abraham, C. Hermans, 2013, Annals of dermatology.

Prospective, randomized, fellow eye comparison of WaveLight® Allegretto Wave® Eye-Q versus VISX CustomVueTM STAR S4 IRTM in photorefractive keratectomy: analysis of visual outcomes and higher-order aberrations

J. Rakic, K. Denhaerynck, I. Abraham, 2011, Clinical Ophthalmology.

Patient- and physician-level determinants of blood pressure response to treatment in normal weight and overweight patients (the PREVIEW study).

I. Abraham, C. Hermans, P. Van der Niepen, 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Antihypertensive effectiveness of aliskiren for the ‘real‐world’ management of hypertension: multilevel modelling of 180‐day blood pressure outcomes (the Belgian DRIVER Study)

I. Abraham, C. Hermans, K. MacDonald, 2011, International journal of clinical practice.

International Journal of General Medicine Dovepress Dovepress 163 R a P I D C O M M U N I C at I O N

C. Hermans, K. MacDonald, S. Vancayzeele, 2022 .